{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diabetic+Autonomic+Neuropathy", "query": { "condition": "Diabetic Autonomic Neuropathy" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 21, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diabetic+Autonomic+Neuropathy&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-23T19:01:12.577Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00594152", "title": "Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Nephropathy", "Diabetic Retinopathy" ], "interventions": [ { "name": "CIIIT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Joslin Diabetes Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 71, "start_date": "1993-01", "completion_date": "1995-01", "has_results": false, "last_update_posted_date": "2008-01-15", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00594152" }, { "nct_id": "NCT00782340", "title": "A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Symptomatic Neurogenic Orthostatic Hypotension (NOH)", "Non-diabetic Neuropathy", "Primary Autonomic Failure", "Dopamine Beta Hydroxylase Deficiency" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Droxidopa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chelsea Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 263, "start_date": "2008-09", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2014-05-16", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 14, "location_summary": "Huntsville, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 11 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Irvine", "state": "California" }, { "city": "Bradenton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00782340" }, { "nct_id": "NCT00116207", "title": "An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Autonomic Neuropathy" ], "interventions": [ { "name": "ORAL ANTIOXIDANT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 44, "start_date": "2000-01", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2016-07-29", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00116207" }, { "nct_id": "NCT00760955", "title": "Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Neuropathies" ], "interventions": [ { "name": "TAK-583", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 338, "start_date": "2006-09", "completion_date": "2008-02", "has_results": false, "last_update_posted_date": "2016-06-22", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 33, "location_summary": "Mesa, Arizona • Peoria, Arizona • Phoenix, Arizona + 30 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00760955" }, { "nct_id": "NCT02795052", "title": "Neurologic Stem Cell Treatment Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Neurologic Disorders", "Nervous System Diseases", "Neurodegenerative Diseases", "Neurological Disorders", "Stroke", "Traumatic Brain Injury", "Cadasil", "Chronic Traumatic Encephalopathy", "Cerebral Infarction", "Cerebral Ischemia", "Cerebral Stroke", "Cerebral Hemorrhage", "Parkinson", "Multi-System Degeneration", "MSA - Multiple System Atrophy", "Progressive Supranuclear Palsy", "ALS", "Amyotrophic Lateral Sclerosis", "Neuropathy", "Diabetic Neuropathies", "Alzheimer Disease", "Dementia", "Frontotemporal Dementia", "Lewy Body Disease", "Cognitive Impairment", "Lewy Body Variant of Alzheimer Disease" ], "interventions": [ { "name": "Intravenous and Intranasal BMSC", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "MD Stem Cells", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2016-06", "completion_date": "2028-07-31", "has_results": false, "last_update_posted_date": "2026-06-26", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 2, "location_summary": "Westport, Connecticut • Coral Springs, Florida", "locations": [ { "city": "Westport", "state": "Connecticut" }, { "city": "Coral Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02795052" }, { "nct_id": "NCT00619983", "title": "Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetic Neuropathic Pain", "Chronic Low Back Pain" ], "interventions": [ { "name": "donepezil", "type": "DRUG" }, { "name": "duloxetine", "type": "DRUG" }, { "name": "donepezil 2.5 mg and duloxetine 30mg", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 22, "start_date": "2008-02", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2018-09-11", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 2, "location_summary": "Winston-Salem, North Carolina • Cleveland, Ohio", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00619983" }, { "nct_id": "NCT00855439", "title": "Evaluation of Exenatide in Patients With Diabetic Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes Mellitus", "Diabetic Peripheral Neuropathy" ], "interventions": [ { "name": "Exenatide", "type": "DRUG" }, { "name": "Glargine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 46, "start_date": "2008-06", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2017-03-01", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00855439" }, { "nct_id": "NCT07005947", "title": "Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Long COVID-19", "Acute COVID-19", "Postural Orthostatic Tachycardia Syndrome (POTS)", "Diabetic Neuropathy" ], "interventions": [], "intervention_types": [], "sponsor": "CND Life Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 237, "start_date": "2023-11-30", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2026-07-02", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 1, "location_summary": "Scottsdale, Arizona", "locations": [ { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07005947" }, { "nct_id": "NCT03426085", "title": "The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autonomic Nervous System Diseases", "Sweat Gland Diseases", "Diabetic Neuropathy With Neurologic Complication" ], "interventions": [ { "name": "Liraglutide 6 mg Solution for Injection", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Eastern Virginia Medical School", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 44, "start_date": "2016-05", "completion_date": "2020-08", "has_results": false, "last_update_posted_date": "2019-02-11", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 1, "location_summary": "Norfolk, Virginia", "locations": [ { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03426085" }, { "nct_id": "NCT02682901", "title": "Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetic Autonomic Neuropathy" ], "interventions": [ { "name": "Cycloset", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eastern Virginia Medical School", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "30 Years to 80 Years" }, "enrollment_count": 84, "start_date": "2015-10-05", "completion_date": "2018-11-15", "has_results": true, "last_update_posted_date": "2021-12-10", "last_synced_at": "2026-07-23T19:01:12.577Z", "location_count": 1, "location_summary": "Norfolk, Virginia", "locations": [ { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02682901" } ] }